ArticleActa pharmaceutica Sinica. B2026
Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1.
Taoling Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleActa pharmaceutica Sinica. B2026
Taoling Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.